CATALYSTYahoo Finance • 22h ago
All You Need to Know About OmniAb, Inc. (OABI) Rating Upgrade to BuyYahoo Finance report covering OmniAb Inc. (OABI) market action, institutional positioning, and fundamental catalysts.
Why OABI Stock slipped -0.39% Today — RQD Quant Desk Flash
$5.09 -0.39% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $5.08
OmniAb Inc. (OABI) carries a Roarable Rating of D (Sell) with 44/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D • SELL / AVOID
Cap $742.9M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on OABI Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is OABI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-03, OmniAb Inc. (NASDAQ: OABI) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 44/100 at a spot price of $5.09 (-0.39% 1D, market cap $742.9M). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 16/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 3/20. Across 1015 tracked Health Care issuers, OABI ranks #388 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does OABI compare to NRC and ABSI in the Health Care sector?
▼
Within the Health Care sector (Biotechnology: Commercial Physical & Biological Resarch), OABI carries a Roarable D (44/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -22.6%. By comparison, NRC (NRC Health) holds a C+ grade (67/100 RQD, P/E 44.8x, ROIC 21.0%, cap $527.1M) and ABSI (Absci Corporation) posts a D grade (44/100 RQD, P/E N/A, ROIC -35.0%, cap $1.91B). Among the 5-stock peer group, NRC leads on earnings multiple (44.8x) while NRC leads on capital efficiency (21.0% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for OABI?
▼
Per OABI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001846253), OmniAb Inc. generated $18.7M in revenue (-29.3% YoY), -$64.8M in net income, and -$37.0M in free cash flow against $300.9M in total assets and $0 in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $5.08 (-0.26%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 9/20 (D) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (44/100 · D) historically underperformed SPY in 71% of rolling 90-day windows (-6.5% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERSELL / AVOID • D
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D · Rk D-
Each axis scored 0–20
12M PRICE TARGET CONE-6.3% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for OABI)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (44/100 Composite)
🔍 WHY OABI SCORES 44/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Whale & Options Positioning+16/20 pts (36% of score)
20D Institutional Volume Accumulation (±12.5% realized swing band)
▲ #2 Bullish Driver: Cash Engine Quality+9/20 pts (20% of score)
SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 52% Gross Margin
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)
Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade E$4.70+5.5% Next Q
36
Q2 (-2Q)Grade E$4.96+0% Next Q
39
Q3 (-1Q)Grade D$4.96+2.6% Next Q
41
CurrentGrade D$5.09-6.5% Hist 90D α
44
Trajectory: E (36) → D (44)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a OABI Turnaround Squeeze
While OABI currently carries a cautious 44/100 (D) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Big institutional funds and options desks are actively positioning on the bullish side.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($4.68) and Max Pain ($5.34) forces dealer call-delta covering toward $5.70.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $OABI• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “OABI Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why OABI Stock slipped -0.39% Today — RQD Quant Desk Flash
OmniAb Inc. (OABI) slipped -0.39% to $5.09, trading at 92% of its 52-week range ($1.3 – $5.43). Stretched risk/reward at current multiples (-23% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 92% of its 52-week range ($1.3 – $5.43) with RSI-14 at 57.5 (BULLISH MOMENTUM).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $5.09 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D (Sell) backed by 52% gross margin and $0 annual free cash flow.
Live OABI Headlines & Catalysts
MARKET WIREMoomoo • 1d ago
OmniAb(OABI) Stock Options Chain | Quotes & NewsMoomoo report covering OmniAb Inc. (OABI) market action, institutional positioning, and fundamental catalysts.
CATALYSTSeeking Alpha • 1d ago
OmniAb: A Self-Funding Option Book On 433 Partner ProgramsSeeking Alpha report covering OmniAb Inc. (OABI) market action, institutional positioning, and fundamental catalysts.
CATALYSTChartMill • 1d ago
OmniAb Inc. (NASDAQ:OABI) Q3 2026 Revenue Beat and Raised Guidance Offset by Sell-the-News PressureChartMill report covering OmniAb Inc. (OABI) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo Finance • 1d ago
OmniAb (OABI) Q3 Results Keep Cash Progress In FocusYahoo Finance report covering OmniAb Inc. (OABI) market action, institutional positioning, and fundamental catalysts.
MARKET WIREMoomoo • 1d ago
OmniAb (OABI) Stock Forum and DiscussionMoomoo report covering OmniAb Inc. (OABI) market action, institutional positioning, and fundamental catalysts.
MARKET WIRESeeking Alpha • 1d ago
OmniAb, Inc. (OABI) Analyst/Investor Day - Slideshow (NASDAQ:OABI) 2026-10-06Seeking Alpha report covering OmniAb Inc. (OABI) market action, institutional positioning, and fundamental catalysts.
CATALYSTSimply Wall St • 1d ago
OmniAb (OABI) Stock Price Slips As Q3 Results Raise Cash Burn QuestionsSimply Wall St report covering OmniAb Inc. (OABI) market action, institutional positioning, and fundamental catalysts.
MARKET WIREYahoo • 3d ago
OmniAb, Inc. Q3 2026 Earnings Call SummaryMoby summary of OmniAb, Inc.'s Q3 2026 earnings call
CATALYSTYahoo • 3d ago
OmniAb (OABI) Q3 2026 Earnings Call TranscriptRevenue jumped to $4M as xPloration expands and Lilly partnership unlocks $3B in milestones.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring OABI)
- ✓Walkthrough of OABI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
OABI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +260.99%⚡ TESTING RESISTANCE
2026-11-03O $5.23H $5.23L $5.09C $5.09VOL 2.11M
RES: $5.41SUP: $4.43SMA50: $4.68SMA200: $2.74
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
OABI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth
vs. -29.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger
No active Ellis Vennor swing setup published on OABI today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for OABI. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for OABI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (OABI)
Health Care Rank #388 of 1015
⚔️ NRC vs OABI Full Matrix →
1. Head-to-Head Health Care Peer Comparison (OABI vs. NRC, ABSI, MXCT, ICLR)
Industry: Biotechnology: Commercial Physical & Biological Resarch (12 Tracked Issuers)Across 1015 tracked Health Care securities in the Roarable RQD universe, OmniAb Inc. (OABI) ranks #388 by composite RQD confidence (44/100, grade D) and #390 by equity capitalization ($742.9M). Within this direct 5-issuer industry benchmark cohort, NRC leads on earnings valuation at 44.8x trailing P/E, while NRC leads on capital efficiency and profitability with 21.0% ROIC and — gross margin. ICLR currently holds the highest overall quantitative score in the immediate peer group at 72/100 (B) compared with OABI at 44/100 (D).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| OABI
ACTIVE
OmniAb Inc. | D | 44/100 | — | — | -22.6% | -0.39% | $742.9M | Benchmark Subject |
| NRC NRC Health | C+ | 67/100 | 44.8x | — | 21.0% | +1.80% | $527.1M | /nrc-vs-oabi → |
| ABSI Absci Corporation | D | 44/100 | — | — | -35.0% | -12.94% | $1.91B | /absi-vs-oabi → |
| MXCT MaxCyte Inc. | E | 34/100 | — | 96.0% | -27.1% | -8.80% | $164.1M | /mxct-vs-oabi → |
| ICLR ICON plc | B | 72/100 | 71.9x | — | 3.1% | -2.94% | $16.18B | /iclr-vs-oabi → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001846253 ↗In its most recent audited fiscal period (FY2025, filed 2025-12-31), OmniAb Inc. (OABI) reported GAAP revenue of $18.7M (-29.3% vs. FY2024 revenue of $26.4M , and -45.4% cumulative change since FY2023) , GAAP net income of -$64.8M, operating cash flow of -$36.5M, and free cash flow of -$37.0M (+10.9% YoY). On the balance sheet, OABI closed FY2025 with $300.9M in total assets against $0 in total debt (Altman Z-Score: 12.19, Piotroski F-Score: 2/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $18.7M | -$64.8M | -$36.5M | -$37.0M | $300.9M | — |
| FY2024 (FY) | 2024-12-31 | $26.4M | -$62.0M | -$39.7M | -$41.5M | $325.6M | — |
| FY2023 (FY) | 2023-12-31 | $34.2M | -$50.6M | $2.3M | $2.3M | — | — |
3. OABI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs OABI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-03, OmniAb Inc. (NASDAQ: OABI) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 44/100 at a spot price of $5.09 (-0.39% 1D, market cap $742.9M). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 16/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 3/20. Across 1015 tracked Health Care issuers, OABI ranks #388 in composite RQD confidence.
How does OABI compare to NRC and ABSI in the Health Care sector?
Within the Health Care sector (Biotechnology: Commercial Physical & Biological Resarch), OABI carries a Roarable D (44/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -22.6%. By comparison, NRC (NRC Health) holds a C+ grade (67/100 RQD, P/E 44.8x, ROIC 21.0%, cap $527.1M) and ABSI (Absci Corporation) posts a D grade (44/100 RQD, P/E N/A, ROIC -35.0%, cap $1.91B). Among the 5-stock peer group, NRC leads on earnings multiple (44.8x) while NRC leads on capital efficiency (21.0% ROIC).
What are the biggest fundamental strengths and SEC risk factors for OABI?
Per OABI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001846253), OmniAb Inc. generated $18.7M in revenue (-29.3% YoY), -$64.8M in net income, and -$37.0M in free cash flow against $300.9M in total assets and $0 in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.
Where is OABI trading relative to its 50-day, 200-day, and 52-week technical levels?
OABI last traded at $5.09 (-0.39% on volume of 2,148,686 shares), positioning the stock +8.76% above its 50-day simple moving average ($4.68) and +85.77% above its 200-day simple moving average ($2.74). Across its 52-week range of $1.30 to $5.43, OABI sits at the 91.8% percentile with a 14-day RSI of 57.5 (BULLISH MOMENTUM) and an implied next-earnings move of ±12.5% ($4.45 to $5.73).
ROARABLE RATING BRIEF • RQD 44/100 (D)
✓ SEC XBRL & RQD VERIFIED
OABI — OmniAb Inc.: What the Facts Mean to a Prospective Investor
Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31
1. Roarable Rating Brief: What This Means to a Prospective Investor
OmniAb Inc. (OABI) earns a live Roarable RQD composite score of 44/100, corresponding to a D letter grade (Roarable Sell) at a spot price of $5.09 (-0.39% 1D, market capitalization $742.9M).
- Fundamental Cash Engine (9/20): Anchored by return on invested capital (ROIC) of -22.6%, gross margin of —, operating margin of -60.0%, and free cash flow yield of -4.87%.
- Whale 13F & Options Flow (16/20) + Insider Conviction (3/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
- Macro Regime Fit (8/20) + Forensic Balance Sheet (8/20): Incorporates a 1.00x equity beta, Altman Z-Score of 12.19, Piotroski F-Score of 2/9, and Debt/Equity of N/A.
2. Business Model, Unit Margins & SEC Financial Trajectory
OmniAb Inc. Is a NASDAQ-listed issuer in the Health Care sector, operating in the Biotechnology: Commercial Physical & Biological Resarch industry. Market capitalization is listed as $0.8B in the company profile.
In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), OmniAb Inc. (OABI) reported $18.7M in annual revenue (up from $26.4M in FY2024, -29.3% YoY) and -$64.8M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($34.2M revenue, -$50.6M net income) through FY2025, OABI scaled operating cash flow to -$36.5M and free cash flow to -$37.0M, backed by $300.9M in total assets against $0 in total debt.
3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff
- 🐂 Primary Bull Case (D • RQD 44/100): Big institutional funds and options desks are actively positioning on the bullish side. Free cash flow yield of -4.87% and institutional whale pillar of 16/20. With Fundamental Cash Engine at 9/20 and Institutional Whale Flow at 16/20, sustained execution supports upside toward the upper end of the $1.30 – $5.43 52-week range.
- 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -60.0% operating margins and a 1.00x macro beta.
4. 2nd-Order Butterfly Ripples & Key Questions to Watch
A prospective investor should note that the sector-level sensitivity cited in the RQD macro pillar is the only sector-linkage information available.
- Key Question #1: Can OABI sustain or expand its -60.0% operating margin and -22.6% ROIC against Biotechnology: Commercial Physical & Biological Resarch peers over the next 4 quarters?
- Key Question #2: Following FY2025 revenue of $18.7M and free cash flow of -$37.0M, how will capital allocation balance growth reinvestment against $0 in total debt?
- Key Question #3: How sensitive is OABI's equity valuation to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?
OABI Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for OmniAb Inc. (OABI) • Click "Debate This Headline" to argue it in the Roar Pit below
🟢 CATALYST Yahoo Finance • 22h ago
All You Need to Know About OmniAb, Inc. (OABI) Rating Upgrade to Buy Yahoo Finance report covering OmniAb Inc. (OABI) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Moomoo • 1d ago
OmniAb(OABI) Stock Options Chain | Quotes & News Moomoo report covering OmniAb Inc. (OABI) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST Seeking Alpha • 1d ago
OmniAb: A Self-Funding Option Book On 433 Partner Programs Seeking Alpha report covering OmniAb Inc. (OABI) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST ChartMill • 1d ago
OmniAb Inc. (NASDAQ:OABI) Q3 2026 Revenue Beat and Raised Guidance Offset by Sell-the-News Pressure ChartMill report covering OmniAb Inc. (OABI) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Yahoo Finance • 1d ago
OmniAb (OABI) Q3 Results Keep Cash Progress In Focus Yahoo Finance report covering OmniAb Inc. (OABI) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Moomoo • 1d ago
OmniAb (OABI) Stock Forum and Discussion Moomoo report covering OmniAb Inc. (OABI) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Seeking Alpha • 1d ago
OmniAb, Inc. (OABI) Analyst/Investor Day - Slideshow (NASDAQ:OABI) 2026-10-06 Seeking Alpha report covering OmniAb Inc. (OABI) market action, institutional positioning, and fundamental catalysts.
🟢 CATALYST Simply Wall St • 1d ago
OmniAb (OABI) Stock Price Slips As Q3 Results Raise Cash Burn Questions Simply Wall St report covering OmniAb Inc. (OABI) market action, institutional positioning, and fundamental catalysts.
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
OABI Bull vs. Bear Conversation Board — What's Your Call at $5.09?
🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON OABI 🐻 33% BEARISH CONVICTION
MI MidwestValue RQD DEBATE OPENER • Fundamental Long-Only 🐂 BULLISH
🎯 Target: $6.39 (+25.0%)
📌 Pinned Debate Institutional whale-flow scores 16/20 and the Altman Z-Score of 12.19 signals low near-term distress risk despite operating losses.
Don't sleep on OABI's setup in Health Care. Institutional whale-flow scores 16/20 and the Altman Z-Score of 12.19 signals low near-term distress risk despite operating losses.. Beta of 1.0 means it moves fast when momentum turns, and the 5-pillar RQD gauge (44/100) backs up the fundamental quality.
CapAlloc_Nerd 🐂 BULL
@MidwestValue Agree on the RQD 44/100 quality, though with 1.0 beta I'm scaling in with half-size at $5.11 and keeping dry powder in case we test $4.75.
MU MultipleCompression RQD DEBATE OPENER • Valuation Discipline 🐻 BEARISH
🎯 Target: $3.88 (-24.1%)
Spot @ $5.11 Revenue fell from $34.2M to $18.7M across FY 2023–FY 2025 while FCF stayed negative, with insider conviction scored just 3/20.
Sitting on the sidelines or leaning short OABI above $5.11. Revenue fell from $34.2M to $18.7M across FY 2023–FY 2025 while FCF stayed negative, with insider conviction scored just 3/20.. Until Fundamental Cash Engine (9/20) and FCF yield (-4.87%) inflect higher, upside is capped near $5.43.